8291 - 8300 of 8571 Results
Title
Year
- Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's Disease2021OPENTitle: Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 302End Page: 314Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28849Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28849Citation Count: 25
-
OPENTitle: Cerebello‐Cortical Control of Tremor Rhythm and Amplitude in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1727End Page: 1729Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28603Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28603Citation Count: 34
- Subcutaneous Levodopa Infusion for Parkinson's Disease: 1‐Year Data from the Open‐Label BeyoND Study2021OPENTitle: Subcutaneous Levodopa Infusion for Parkinson's Disease: 1‐Year Data from the Open‐Label BeyoND StudyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2687End Page: 2692Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28758Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28758Citation Count: 31
- Cerebrospinal α‐Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal Cohort2021OPENTitle: Cerebrospinal α‐Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal CohortJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2048End Page: 2056Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28611Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28611Citation Count: 32
-
OPENTitle: Corneal Confocal Microscopy Identifies Parkinson's Disease with More Rapid Motor ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1927End Page: 1934Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28602Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28602Citation Count: 27
- CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLB2021OPENTitle: CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLBJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2595End Page: 2604Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28704Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28704Citation Count: 19
- A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson’s Disease in Participants With Leucine‐Rich Repeat Kinase 2 Mutation2021OPENTitle: A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson’s Disease in Participants With Leucine‐Rich Repeat Kinase 2 MutationJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 110Issue #: 2Start Page: 508End Page: 518Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cpt.2277Citation Count: 13
- Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant Epilepsy2021OPENTitle: Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant EpilepsyJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 110Issue #: 5Start Page: 1368End Page: 1380Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/cpt.2408Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2408Citation Count: 31
-
OPENTitle: Antiepileptogenesis and disease modification: Clinical and regulatory issuesJournal Name: Epilepsia OpenPublisher: WileyVol: 6Issue #: 3Start Page: 483End Page: 492Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/epi4.12526Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/epi4.12526Citation Count: 30
-
OPENTitle: Worldwide barriers to genetic testing for movement disordersJournal Name: European Journal of NeurologyPublisher: WileyVol: 28Issue #: 6Start Page: 1901End Page: 1909Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/ene.14826Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14826Citation Count: 35